FIELD: medicine; hematology.
SUBSTANCE: invention concerns a method for morphometric prediction of the course of diffuse large B-cell lymphoma (DLBCL) by the content of AIF-positive tumor cells in the lymph nodes. The method includes immunohistochemical staining in histological sections after biopsy of lymph nodes and morphometric calculation of the relative number of AIF-positive tumor cells according to the formula. As a result, at the values of AIF-positive tumor cells ≥ 57% a favorable course of diffuse large B-cell lymphoma is predicted. When the content of AIF-positive cells < 57% an unfavorable course of the disease is predicted.
EFFECT: method is informative, can be used in practical hematology to predict the course of DLBCL and select the optimal therapeutic approach.
1 cl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF MORPHOMETRIC PREDICTION OF COURSE OF DIFFUSE LARGE B-CELL LYMPHOMA BASED ON CONTENT OF p16INK4A- AND p14ARF-POSITIVE TUMOUR CELLS IN LYMPH NODES | 2023 |
|
RU2814849C1 |
METHOD FOR MORPHOMETRIC PREDICTION OF THE COURSE OF DIFFUSE LARGE B-CELL LYMPHOMA BY THE CONTENT OF P14ARF-POSITIVE TUMOR CELLS IN THE LYMPH NODES | 2022 |
|
RU2785907C1 |
METHOD FOR MORPHOMETRIC ESTIMATION OF THE PROGNOSIS OF THE COURSE OF DIFFUSE LARGE B-CELL LYMPHOMA BY THE INDEX OF THE PROPORTION OF TUMOUR CELLS EXPRESSING PSTAT3 AND PAKT1 IN LYMPH NODES | 2021 |
|
RU2767693C1 |
METHOD FOR MORPHOMETRIC ASSESSMENT OF THE PREDICTION OF DIFFUSE B-LARGE-CELL LYMPHOMA BY CONTENT OF STAT3+ CELLS IN TUMOR TISSUE | 2019 |
|
RU2710591C1 |
METHOD FOR MORPHOMETRIC ASSESSMENT OF A DIFFUSE B-LARGE-CELL LYMPHOMA PREDICTION BY STAT3+ TUMOR CELL COUNT IN LYMPH NODES | 2018 |
|
RU2694838C1 |
METHOD OF DIFFERENTIAL DIAGNOSTICS OF DIFFUSE LARGE B-CELL LYMPHOMAS | 2020 |
|
RU2750103C1 |
METHOD FOR PREDICTING THE DEVELOPMENT OF RECURRENCE OF DIFFUSE LARGE B-CELL LYMPHOMA | 2021 |
|
RU2758126C1 |
METHOD FOR MORPHOMETRIC ESTIMATION OF PREDICTION OF CLINICAL COURSE OF NODULAR SCLEROSIS OF HODGKIN LYMPHOMA BY A PERCENTAGE SCORE CD163+ AND CD68+ MACROPHAGES IN LYMPH NODES | 2020 |
|
RU2738863C1 |
METHOD FOR PREDICTION OF SENSITIVITY TO CHEMOTHERAPY IN PATIENTS SUFFERING FROM LYMPHOPROLIFERATIVE DISEASES | 2015 |
|
RU2593020C2 |
METHOD OF PREDICTING EFFICIENCY OF TREATMENT OF PATIENTS WITH HIGH GRADE NON-HODGKIN LYMPHOMA | 2013 |
|
RU2533816C2 |
Authors
Dates
2023-06-29—Published
2023-01-23—Filed